• Markets
  • icon
  • Companies
ME1 · ASX

Melodiol Global Health Limited (ASX:ME1)

AU$0.003

 0.0 (0.0%)
ASX:Live
17/05/2024 02:55:02 PM
HALO Ords GROWTH AUS Big Candle All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

ME1 Overview

ME1 Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About ME1

Telephone

Address

Description

Melodiol Global Health Ltd. engages in the developing, register and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. It operates through the following geographical segments: Europe includes Creso Pharma Switzerland GmbH, Canada includes the operating companies; Mernova Medicinal Inc, Halucenex Life Sciences Inc., Creso Impactive Ltd, United States of America, and Creso Pharma Limited in Australia. The company was founded by Adam Blumenthal, Miri Halperin Wernli and Boaz Wachtel on November 20, 2015 and is headquartered in Nedlends, Australia.

ME1 Price Chart

Key Stats

Market Cap

AU$2.14M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.3

Trade Value (12mth)

AU$20,885.00

1 week

20%

1 month

-25%

YTD

-85%

1 year

-99.06%

All time high

33.0

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

0.00%

Operating Cashflow

-$9m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

N/A

Quick Ratio

0.00

Other Data

Shares on Issue (Fully Dilluted)

109m

HALO Sector

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

ME1 Announcements

Latest Announcements

Date Announcements

09 May 24

Trading Update

×

Trading Update

03 May 24

Application for quotation of securities - ME1

×

Application for quotation of securities - ME1

03 May 24

Secondary Trading Notice

×

Secondary Trading Notice

02 May 24

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

02 May 24

Consolidation/Split - ME1

×

Consolidation/Split - ME1

02 May 24

Proposed issue of securities - ME1

×

Proposed issue of securities - ME1

30 April 24

Board Change

×

Board Change

30 April 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

30 April 24

Appointment of Tim Tian as Group CFO

×

Appointment of Tim Tian as Group CFO

30 April 24

Proposed issue of securities - ME1

×

Proposed issue of securities - ME1

30 April 24

Final Director's Interest Notice

×

Final Director's Interest Notice

22 April 24

Application for quotation of securities - ME1

×

Application for quotation of securities - ME1

22 April 24

Secondary Trading Notice

×

Secondary Trading Notice

22 April 24

Update - Proposed issue of securities - ME1

×

Update - Proposed issue of securities - ME1

19 April 24

Response to ASX Aware Letter

×

Response to ASX Aware Letter

19 April 24

Corporate Update

×

Corporate Update

19 April 24

Proposed issue of securities - ME1

×

Proposed issue of securities - ME1

16 April 24

ME1 Q1 FY24 Revenue

×

ME1 Q1 FY24 Revenue

09 April 24

Melodiol Global Health Limited - Health House Australia and Corporate Update (ME1-AU)

×

Melodiol Global Health Limited - Health House Australia and Corporate Update (ME1-AU)

09 April 24

Melodiol Global Health Limited - Application for quotation of securities - ME1 (ME1-AU)

×

Melodiol Global Health Limited - Application for quotation of securities - ME1 (ME1-AU)

09 April 24

Melodiol Global Health Limited - Proposed issue of securities - ME1 (ME1-AU)

×

Melodiol Global Health Limited - Proposed issue of securities - ME1 (ME1-AU)

08 April 24

Melodiol Global Health Limited - Extension of Cleansing Offer Closing Date (ME1-AU)

×

Melodiol Global Health Limited - Extension of Cleansing Offer Closing Date (ME1-AU)

02 April 24

Melodiol Global Health Limited - Mernova Trading Update (ME1-AU)

×

Melodiol Global Health Limited - Mernova Trading Update (ME1-AU)

02 April 24

Melodiol Global Health Limited - Application for quotation of securities - ME1 (ME1-AU)

×

Melodiol Global Health Limited - Application for quotation of securities - ME1 (ME1-AU)

02 April 24

Melodiol Global Health Limited - Proposed issue of securities - ME1 (ME1-AU)

×

Melodiol Global Health Limited - Proposed issue of securities - ME1 (ME1-AU)

ME1 Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock N/A N/A 0.00 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock N/A N/A 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock N/A N/A 0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock N/A N/A 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
DPS $ Lock Lock Lock Lock N/A N/A 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
BPS $ Lock Lock Lock Lock N/A N/A 0.00 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock N/A N/A 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Basic m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock N/A N/A 22 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock N/A N/A -9 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock N/A N/A 9 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock N/A N/A -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A -0.4 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock N/A N/A 1 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Equity $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Invested Capital Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Equity % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Equity % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

ME1 Shortsell

Frequently Asked Questions

The current share price of Melodiol Global Health Limited (ME1:ASX) is AU$0.003.
The 52-week high share price for Melodiol Global Health Limited (ME1:ASX) is AU$0.30.
The 52-week low share price for Melodiol Global Health Limited (ME1:ASX)? is AU$0.00.
Melodiol Global Health Limited (ME1:ASX) does not pay a dividend.
Melodiol Global Health Limited (ME1:ASX) does not pay a dividend.
Melodiol Global Health Limited (ME1:ASX) has a franking level of 0.0%.
Melodiol Global Health Limited (ME1:ASX) is classified in the Healthcare.
The current P/E ratio for Melodiol Global Health Limited (ME1:ASX) is .